ARTV
Artiva Biotherapeutics, Inc.
NASDAQ · USHealthcareBiotechnology
$9.63-1.38%
Price as of Jul 20, 2026
ARTV earnings
Artiva Biotherapeutics, Inc. earnings
Reported EPS and revenue history, upcoming estimates and available earnings-call summaries.
Next earnings
Aug 5, 2026in NaN days
EPS est $-0.64 · Revenue est —
Track record
Beat EPS in 2 of 6 quarters
Avg surprise -7.3% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 8, 2026 | $-0.88 | $-0.95 | -8.0% | — | — |
| Nov 12, 2025 | $-0.92 | $-0.88 | +4.3% | — | — |
| Aug 6, 2025 | $-0.84 | $-0.87 | -3.6% | — | — |
| May 8, 2025 | $-0.68 | $-0.83 | -22.1% | — | — |
| Mar 25, 2025 | $-0.71 | $-0.66 | +7.0% | — | — |
| Aug 29, 2024 | $-4.40 | $-22.00 | -400.0% | $251000 | — |
| Jun 29, 2024 | — | $-0.62 | — | — | — |
| Dec 30, 2023 | — | $-0.30 | — | $33M | — |
| Sep 30, 2023 | — | $1.20 | — | $27M | — |
Earnings history is derived from company filings and calendar data. Call summaries are grouped by reporting period. Latest covered event: 2026-08-05.